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ABSTRACT
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease
mainly  affects  respiratory  system.  Its  common clinical findings  include  fever,  cough and shortness  of  breath.  Characteristic  radiological
features of the disease include peripherally distributed, bilateral ground-glass opacities, predominantly involving the lower lung zones. In
this report, we present a case of COVID-19 disease presenting with spontaneous pneumothorax. A 26-year male patient was admitted to the
Emergency Department with fever, dry cough, shortness of breath and right-sided chest pain. Radiographic imaging of the patient
revealed pneumothorax on the right and peripherally distributed non-homogenous opacification. The patient underwent right lateral tube
thoracostomy. COVID-19 was diagnosed on testing of nasopharyngeal swab. In conclusion, spontaneous pneumothorax is one of the rare
presentations of COVID-19 pneumonia and should be kept in mind in patients presenting with shortness of breath and chest pain.
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INTRODUCTION
The coronavirus disease 2019 (COVID-19) is caused by severe
acute  respiratory  syndrome  coronavirus  2  (SARS-CoV-2).1
SARS-CoV-2  is  a  member  of  the  coronaviridae  family  and
contains a single stranded RNA.1,2 In December 2019, a new
case of coronavirus infection occurred in Wuhan, China.1 The
new coronavirus was identified on January 6, 2020 and labelled
as  2019-nCoV.3  Worldwide,  more than 6,  057,  853  cases  of
COVID-19 and 371,166 COVID-19-related  deaths  have been
reported till 1st June 2020.4
The  clinical  features  of  mild  COVID-19  include  symptoms
common  to  other  viral  infections,1  while  clinical  features  of
severe COVID-19 include pneumonia, acute respiratory distress
syndrome (ARDS) and shock.5
Chest radiographs show low-density pneumonia, which mostly
involves bilateral mid-lower zones. In computed tomography
(CT),  the  most  common  radiological  finding  is  ground-glass
appearance.6 In this report, we present a case of COVID-19 pneu-
monia, who was admitted with spontaneous pneumothorax and
recovered completely.
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CASE REPORT
A 26-year man was admitted to the Emergency Department
(ED) with the complaints of fever, cough, shortness of breath,
and right-sided pleuritic chest pain. He was in usual state of
health three days back when he started having fever with dry
cough. He denied body aches and flu-like symptoms. He took
paracetamol for fever. His condition did not get better and he
started having right-sided pleuritic chest pain one day before
presenting to ED. His past medical history was unremarkable.
He did not smoke and there was no travel history in recent past.
He was in respiratory distress on presentation. Blood pressure
was 110/70 mmHg, pulse 124/min, respiratory rate 30/min,
temperature 38.5°C, and oxygen saturation (SpO2) with finger
probe was 88% on room air. Breathing sounds were decreased
on the right side and rest of the examination was unremark-
able.  Arterial  blood  gases  were  done  immediately,  which
revealed a pH of 7.45 with a partial pressure of carbon dioxide
of 22 mmHg, partial pressure of oxygen of 66 mmHg, and arte-
rial oxygen saturation of 86% on room air. On chest radiograph,
he was found to have right-sided pneumothorax (Figure 1).
In  blood  tests,  total  leucocyte  count  was  12.06×103/uL,
lymphocytes 1.59×103/uL, hemoglobin 15.4 g/dL, hematocrit
42.4%, platelets 188×103/uL creatinine 0.91 mg/dL, alanine
aminotransferase 13 U/L, aspartate aminotransferase 11 U/L,
lactate dehydrogenase 150 U/, and procalcitonin was 0.043
ng/ml. Patient was put on mechanical ventilation in ED due to
hypoxemia and respiratory distress. He underwent right lateral
tube thoracostomy for pneumothorax and was connected to
thoracic suction. The patient was hospitalised with suspicion of
COVID-19  and  supportive  medical  therapy  was  started.  On
nasopharyngeal swab, SARS-CoV-2 was detected in the poly-
merase chain reaction (PCR). He was stared on intravenous
Intisar  Ahmed,  Hunaina Shahab,  Muhammad Arslan Ahmed and Muhammad Sohaib
Journal  of  the College of  Physicians and Surgeons Pakistan 2021,  Vol.  31 (Supplement 1 COVID-19):S29-S31S30
hydrocortisone and oral hydroxychloroquine. His repeat chest
radiograph after 12 hours showed complete resolution of right-
sided pneumothorax with expansion of right lung and right-
sided  peripherally  located  non-homogenous  opacification
(Figure 2).
 
Figure 1: Chest radiograph on presentation showing right-sided pneu-
mothorax with collapsed right lung.
Figure 2: Chest radiograph after right lateral thoracostomy showing
resolution of pneumothorax with right-sided opacification.
On second day, leak persisted but patient gradually got better
and on third day, was extubated successfully. Other treatment
was  continued.  On  chest  radiograph,  right  lung  was  fully
expanded  but  right-sided  opacification  continued.  Thoracic
suction was stopped and he was connected to an underwater
seal bottle. Patient was shifted out of intensive care unit and
kept in a negative pressure room. On fifth day, he was found to
have no leak and right lung was completely expanded. Thora-
costomy tube was clamped for six hours and repeat chest radio-
graph  showed  no  pneumothorax,  so  tube  was  removed.
Patient was discharged in stable condition on eighth day and
advised  to  remain  in  home isolation  for  another  week.  His
repeat nasopharyngeal swab after one week of discharge did
not detect SARC-CoV-2. His right lung remained expanded on
one week follow-up.
DISCUSSION
Clinical presentations of COVID-19 have ranged from asympto-
matic or mild symptoms to severe illness, respiratory distress
syndrome and mortality. Common presenting symptoms include
fever, cough, and shortness of breath.  Other symptoms, such as
malaise  and  respiratory  distress,  have  also  been  reported.
Huang  et  al.  reported  fever  as  the  most  common  symptom
followed  by  cough,  myalgia  and  fatigue.1  Headache,  sputum
production, and diarrhea were reported as rare clinical presenta-
tions of this disease. All patients with COVID-19 pneumonia have
abnormal lung imaging; and ground-glass opacities are the most
common radiographic findings, especially on computed tomog-
raphy (CT) scan. Pneumothorax has been reported as a very rare
presentation of COVID-19.
Aydin et al.  reported spontaneous pneumothorax in a young
patient with COVID-19.7 There were bilateral irregular consolida-
tion areas. There was no underlying lung disease that would have
predisposed the patient to pneumothorax.7 Salehi et al. investi-
gated imaging findings in 919 COVID-19 positive patients and
detected ground-glass densities in 88% of cases. None of them
developed pneumothorax.8
In severe acute respiratory failure syndrome, sudden alveolar
pressure increase may cause interstitial  emphysema and air
leak, leading to the development of mediastinal emphysema.9 In
a descriptive study, Chen et al. described a case of COVID-19 infec-
tion, presenting with spontaneous pneumothorax.10
In this study, we presented a 26-year man with no underlying
structural lung disease. He presented with COVID-19 pneumonia
and pneumothorax.  Pneumothorax  may develop in  COVID-19
pneumonia due to alveolar damage. This can cause increased
mortality and morbidity. During this pandemic, every patient
with dyspnea and fever should be screened for COVID-19.
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